유럽의 면역진단 시장 예측(-2030년) : 지역별 분석 : 제품별, 임상 적응증별, 최종사용자별
Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User
상품코드:1402521
리서치사:The Insight Partners
발행일:2023년 11월
페이지 정보:영문 209 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유럽의 면역진단 시장은 2023년 61억 3,185만 달러에서 2030년에는 100억 9,803만 달러로 성장할 것으로 예측되고 있습니다. 2023-2030년 CAGR은 7.4%로 추정됩니다.
감염증의 증가가 유럽의 면역진단 시장을 촉진
바이러스, 곰팡이, 박테리아, 기생충 또는 그 독성 산물과 같은 감염성 요인으로 인한 감염증의 진단 및 관리는 보체 고정, 침전 검사, 응집 검사, 라인 블롯 분석, 웨스턴 블롯 분석, 효소 면역 측정(EIA), 면역 형광 검사 등 면역 진단 검사의 처방 수가 급증하고 있습니다. 인간면역결핍바이러스(HIV)는 전 세계에서 공중보건의 큰 문제로 남아있습니다. 또한 결핵(TB), COVID-19 및 기타 병원내 감염(HAI)에 대한 면역진단학 검사가 필요합니다.
결핵은 사망원인 13위, COVID-19에 이어 두 번째로 많은 감염성 질환으로 2020년에는 1,500만 명이 결핵으로 사망했고, 전 세계에서 1,000만 명(남성 560만 명, 여성 330만 명, 어린이 110만 명)이 결핵으로 사망한 것으로 추정됩니다.
Worldometer에 따르면 COVID-19 팬데믹으로 인해 전 세계에서 수백만 명의 사망자가 보고되었습니다. 이 전염병으로 인해 의료 시스템이 지쳐서 면역 진단 검사의 필요성이 높아졌습니다.
진단은 적절한 치료법을 결정하는 데 중요한 역할을 합니다. 면역 진단은 면역 체계에 심각한 영향을 미치는 질병을 진단하는 데 도움이 됩니다. 따라서 감염성 질환의 유행이 증가함에 따라 면역 진단 제품에 대한 수요가 급증하고 있습니다.
유럽의 면역진단 시장 개요
독일의 면역진단 시장을 크게 견인하고 있는 것은 거대한 노인 인구다. 유엔의 인구 데이터에 따르면 독일인 20명 중 1명이 80세 이상 고령자이며, 2050년까지 20명 중 6명으로 증가할 것으로 예상됩니다. 심혈관질환(CVD), 당뇨병, 신경혈관질환 등 만성질환의 발병 위험은 나이가 들수록 높아집니다. 로베르트 코흐 연구소가 2023년 9월에 발표한 독일 암 등록 데이터센터(ZfKD)의 추정에 따르면 2019년 독일에서 50만 2,655명이 암에 걸렸으며, 그 중 여성은 23만 4,925명, 남성은 26만 7,730명이었습니다. 생활습관의 변화, 비만, 불건강한 생활습관 등으로 인해 암의 유병률은 앞으로도 계속 증가할 것으로 추정됩니다. 독일에서 가장 많이 발생하는 암은 유방암, 전립선암, 대장암, 폐암, 방광암입니다. 이 5가지 암은 독일내 신규 암 진단의 약 57%를 차지합니다. 이처럼 암 발병률 증가는 면역 진단에 대한 수요를 촉진할 가능성이 높습니다.
독일은 미국 다음으로 세계 최고의 의료 생명공학 국가로 2020년 독일의 생명공학 부문은 코로나 이전인 2018년에 비해 크게 성장했습니다. 일부 분야는 최근 수년간 긍정적인 시장 추세가 가속화되고 있으며, BIOCOM의 OECD 준수 조사에 따르면 독일 생명공학 산업의 매출은 2020년에 약 50% 증가했습니다. 기존 기업의 존재와 신생 기업의 부상은 산업의 강점을 지원합니다. 산업, 정부 및 연구 부문은 강력한 시장 기반 위에서 번창하고 있습니다. 많은 유럽 생명공학 기업, 세계 최고 수준의 연구 인프라, 국제적으로 유명한 과학자들을 보유한 독일은 국제적인 의료 생명공학 허브로서의 입지를 확고히 하고 있습니다. 독일 생명공학 기업은 유럽의약품청(EMA)의 승인을 받은 최초의 COVID-19 검사 및 백신 접종을 도입함으로써 mRNA 기술 분야의 세계 리더로 부상했습니다. 이러한 발전은 면역 진단의 기술적 진보를 촉진하고 있습니다. 이처럼 생명공학 분야의 부상은 중국의 면역 진단 시장을 촉진할 가능성이 높습니다.
유럽의 면역진단 시장 매출과 2030년까지의 예측(금액)
유럽의 면역진단 시장 세분화
유럽의 면역진단 시장은 제품, 임상 적응증, 최종사용자, 국가별로 구분됩니다.
제품별로 보면 유럽의 면역진단 시장은 효소결합면역흡착측정법(ELISA), 화학 발광 면역측정법(CLIA), 방사면역측정법(RIA), 기타로 구분됩니다. 2023년에는 효소결합면역흡착측정법(ELISA) 분야가 유럽의 면역진단 시장에서 최대 점유율을 기록했습니다. 화학 발광 면역측정법(CLIA) 부문은 또한 비타민 D 어세이 시장, HIV 검출 시장, HIV ag/ab 콤보 어세이 시장, 기타 검사로 구분됩니다.
임상 적응에 기반하여 유럽의 면역진단 시장은 감염증, 간염+HIV, 내분비, 소화기, 대사, 기타로 구분됩니다. 2023년에는 감염증 분야가 유럽의 면역진단 시장에서 최대 점유율을 기록했습니다. 감염증 분야는 또한 COVID-19, 결핵, 라임, 감염 관리, 지카열, 트레포네마, 토치, 홍역·볼거리, VZV, EBV로 구분됩니다. 내분비 분야는 또한 고혈압, 성장, 당뇨병, 갑상선, 생식 내분비로 구분됩니다.
최종사용자별로 보면 유럽의 면역진단 시장은 병원, 클리닉, 진단 연구소, 학술·연구기관, 기타로 구분됩니다. 2023년에는 병원 부문이 유럽의 면역진단 시장에서 최대 점유율을 기록했습니다.
국가별로는 유럽의 면역진단 시장은 독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽으로 구분됩니다. 2023년에는 독일 부문이 유럽의 면역진단 시장에서 최대 점유율을 기록했습니다.
Abbott Laboratories, bioMerieux SA, Danaher Corp, DiaSorin SpA, F. Hoffmann-La Roche Ltd, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Svar Life Science AB, and Thermo Fisher Scientific Inc.는 유럽의 면역진단 시장에 참여하고 있는 대기업입니다.
The Europe immunodiagnostics market is expected to grow from US$ 6,131.85 million in 2023 to US$ 10,098.03 million by 2030. It is estimated to grow at a CAGR of 7.4% from 2023 to 2030.
Increasing Prevalence of Infectious Diseases Drive Europe Immunodiagnostics Market
The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide. Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.
TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.
According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.
Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.
Europe Immunodiagnostics Market Overview
The huge geriatric population is significantly driving the market for immunodiagnostics in Germany. According to the UN population data, 1 out of 20 Germans is aged above 80 years, and the number is expected to increase to 6 out of 20 by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to the estimates of the German Centre for Cancer Registry Data (ZfKD) published by the Robert Koch Institute in September 2023, in Germany, 502,655 people had cancer in 2019, among which 234,925 were women and 267,730 were men. It is estimated that the prevalence of cancer is likely to continue owing to lifestyle changes, obesity, unhealthy habits, and more. The most common cancers in Germany are breast, prostate, colorectum (large bowel), lung, and bladder cancer. These five cancer types accounted for about 57% of all new cancer diagnoses in Germany. Thus, the increasing prevalence of cancer is likely to propel the demand for immunodiagnostics.
Germany is the leading medical biotech nation in the world after the US. In 2020, the German biotechnology sector grew significantly compared to the pre-COVID year 2018. The positive market trend has accelerated in the last few years in some areas; and according to the OECD-compliant survey by BIOCOM, the German biotechnology industry's turnover increased by almost 50% in 2020. The presence of long-established companies and the emergence of start-ups affirmed the industrial strength. Industry, government, and research sectors thrive on strong market foundations. With many European biotech companies, world-class research infrastructure, and internationally renowned scientists, Germany has firmly established itself as an international medical biotechnology hub. German biotech companies emerged as global leaders in mRNA technologies by introducing the first COVID-19 test and vaccination, approved by the European Medicines Agency. Such developments have encouraged enhanced technological advancements for immunodiagnostics. Thus, the rising biotechnology sector will likely boost the country's immunodiagnostics market.
Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Europe Immunodiagnostics Market Segmentation
The Europe immunodiagnostics market is segmented into product, clinical indication, end user, and country.
Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the Europe immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.
Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+hiv, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the Europe immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.
Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the Europe immunodiagnostics market.
Based on country, the Europe immunodiagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered the largest share in the Europe immunodiagnostics market.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe immunodiagnostics market.
Reasons to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunodiagnostics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Immunodiagnostics Market - by Product
1.3.2 Europe Immunodiagnostics Market - by Clinical Indication
1.3.3 Europe Immunodiagnostics Market - by End User
1.3.4 Europe Immunodiagnostics Market - by Country
2. Europe Immunodiagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Immunodiagnostics Market - Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion
5. Europe Immunodiagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market - Europe Analysis
6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis
7. Europe Immunodiagnostics Market Analysis - by Product
7.1 Overview
7.2 Europe Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8. Europe Immunodiagnostics Market Analysis - Clinical Indication
8.1 Overview
8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9. Europe Immunodiagnostics Market Analysis - End User
9.1 Overview
9.2 Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Overview
10.1.1.1 UK: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UK: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3.1 UK: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4 UK: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.1 UK: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.2 UK: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.5 UK: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.3.1 Germany: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4 Germany: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.1 Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.2 Germany: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.5 Germany: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.3.1 France: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4 France: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.1 France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.2 France: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.5 France: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.3.1 Italy: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4 Italy: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.1 Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.2 Italy: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.5 Italy: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.3.1 Spain: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4 Spain: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4.1 Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4.2 Spain: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.5 Spain: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4.1 Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4.2 Rest of Europe: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.5 Rest of Europe: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
11. Europe Immunodiagnostics Market -Industry Landscape
